Monday, November 16, 2009

HeartWare Heart Pump Shows Positive Results in Clinical Study

Filed under: Cardiac Surgery

HeartWare, a Framingham, Massachusetts maker of an innovative left ventricular assist system, released results of a European trial testing the survival rates in patients who've been implanted with the device. Just like other ventricular assist systems, HeartWare® is designed to provide a bridge to heart transplantation.

Our friends over at MassDevice report on the findings:

Data collected from a 50-patient trial aimed at winning CE Mark approval in the European Union (which was granted in January) showed a six-month survival rate of 90 percent, according to a regulatory filing. Two years after implantation the survival rate was 84 percent. Patients 60 years and older had a survival rate of 93 percent.

The study also showed an 80 percent reduction in post-implantation re-hospitalizations in the 12 months after the procedure, compared with the 12 months preceding implantation.

More from MassDevice...

Link: HeartWare regulatory filings at the SEC...

Product page: HeartWare® Ventricular Assist System...

Flashback: Medical Heart Pumps from HeartWare: HVAD, MVAD and PedVAD

                (0)

Name:


Email Address
(will not be published):


URL:

Remember personal info?
(anonymous comments allowed)

Yes No

Comments:

Verification (needed to reduce spam):

Click the "Post" button only once!